WHWK
Whitehawk Therapeutics Inc.

6,401
Mkt Cap
$143.74M
Volume
85,600.00
52W High
$3.77
52W Low
$1.39
PE Ratio
22.46
WHWK Fundamentals
Price
$3.12
Prev Close
$3.00
Open
$3.02
50D MA
$2.69
Beta
1.07
Avg. Volume
108,114.75
EPS (Annual)
-$2.36
P/B
0.91
Rev/Employee
$649,575.00
$38.88
Loading...
Loading...
News
all
press releases
Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?
TEM heads into Q4 earnings with expected 82.8% revenue growth, rising oncology momentum and a premium valuation clouding near-term upside.
Zacks·7d ago
News Placeholder
More News
News Placeholder
Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference Whitehawk Therapeutics to Present at the Oppenheimer 36th Annual Healthcare Life Sciences...
PR Newswire·7d ago
News Placeholder
Should You Buy, Hold or Sell Tempus AI Stock Pre-Q4 Earnings Release?
In preliminary, unaudited financial results, TEM posts 83% revenue growth and record data sales in 2025, but valuation and ongoing GAAP losses cloud the outlook before Q4 earnings.
Zacks·12d ago
News Placeholder
Oppenheimer Initiates Coverage on Whitehawk Therapeutics (NASDAQ:WHWK)
Oppenheimer started coverage on Whitehawk Therapeutics in a report on Thursday. They issued an "outperform" rating and a $6.00 target price on the stock...
MarketBeat·20d ago
News Placeholder
Whitehawk Therapeutics (NASDAQ:WHWK) Trading 0.7% Higher - Still a Buy?
Whitehawk Therapeutics (NASDAQ:WHWK) Stock Price Up 0.7% - Time to Buy...
MarketBeat·20d ago
News Placeholder
Whitehawk Therapeutics (NASDAQ:WHWK) Stock Price Down 2.7% - Here's What Happened
Whitehawk Therapeutics (NASDAQ:WHWK) Trading Down 2.7% - What's Next...
MarketBeat·1mo ago
News Placeholder
Whitehawk Therapeutics (NASDAQ:WHWK) Now Covered by Jones Trading
Jones Trading started coverage on Whitehawk Therapeutics in a research note on Monday. They issued a "buy" rating and a $7.00 price objective on the stock...
MarketBeat·2mo ago
News Placeholder
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer
Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer Whitehawk Therapeutics Appoints Margaret Dugan, MD, as Chief Medical Officer PR Newswire MORRISTOWN, N.J., Dec. 1, 2025...
PR Newswire·3mo ago
News Placeholder
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference Whitehawk Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference PR Newswire...
PR Newswire·3mo ago
News Placeholder
Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London
Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London Whitehawk Therapeutics to Present at Jefferies Global Healthcare Conference in London PR Newswire MORRISTOWN...
PR Newswire·4mo ago
<
1
2
...
>

Latest WHWK News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.